What is the size of the Human Antihistamine Drug market in 2023?

The Human Antihistamine Drug market size is USD 274.8 million in 2023.

What is the projected CAGR at which the Human Antihistamine Drug market is expected to grow at?

The Human Antihistamine Drug market is expected to grow at a CAGR of 9.9% (2024-2033).

List the segments encompassed in this report on the Human Antihistamine Drug market?

Market.US has segmented the Human Antihistamine Drug market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Drug Type the market has been segmented into First-Generation Antihistamines, Second-Generation Antihistamines. By Type the market has been segmented into Prescription-based, Over-the-counter (OTC). By Indication the market has been segmented into Urticaria, Allergy, Atopic Dermatitis, Others. By Route of Administration the market has been segmented into Oral, Parenteral, Others. By End-Users the market has been segmented into Hospitals, Specialty Clinics, Homecare, Others.

List the key industry players of the Human Antihistamine Drug market?

Sanofi, Johnson & Johnson, GlaxoSmithKline (GSK), Bayer AG, Pfizer Inc., Novartis International AG, Merck & Co. Inc., Boehringer Ingelheim, Sun Pharmaceutical Industries Ltd., UCB S.A., and Other Key Players

Which region is more appealing for vendors employed in the Human Antihistamine Drug market?

North America is expected to account for the highest revenue share of 37.2% and boasting an impressive market value of USD 102.2 million. Therefore, the Human Antihistamine Drug industry in North America is expected to garner significant business opportunities over the forecast period.